Advanced Search

Orthopedic Coding Alert

Reader Question:

Synvisc/Hyalgan Injections

Published on Fri Feb 01, 2002

Question: For Synvisc/Hyalgan injections, we usually have to order the medication after precertifying the patients. If the physician has already determined that the patient would benefit from these injections, we do not bill an E/M with the first injection.  Is this correct?

Wyoming Subscriber  
Answer: Yes, you are correct. Because these encounters are scheduled for the expressed purpose of performing the injection, only 20610 (Arthrocentesis, aspiration and/or injection; major joint or bursa [e.g., shoulder, hip, knee joint, subacromial bursa]) and HCPCS code J7320 (Hylan G-F 20, 16 mg, for intra-articular injection) should be reported. It would be appropriate to report an E/M code with these codes if a separate service was rendered for an unrelated condition.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Orthopedic Coding Alert

View All